<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03247439</url>
  </required_header>
  <id_info>
    <org_study_id>PTC-0290</org_study_id>
    <nct_id>NCT03247439</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of Cartiva Implant in the Treatment of First CMC Joint Osteoarthritis Compared to LRTI (GRIP 2)</brief_title>
  <acronym>GRIP 2</acronym>
  <official_title>A Prospective Study to Evaluate the Safety and Effectiveness of the Cartiva® Synthetic Cartilage Implant for CMC in the Treatment of First Carpometacarpal Joint Osteoarthritis as Compared to a Ligament Reconstruction Tendon Interposition (LRTI) Comparator</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cartiva, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cartiva, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate whether Cartiva is an effective treatment for individuals with
      osteoarthritis of the first CMC joint in the hand compared to LRTI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multicenter study with one treatment arm. Comparisons will be made to
      a performance target defined by subtracting a non-inferiority margin of 0.05 from an expected
      standard of care success rate of 0.55. The active treatment arm will receive a Cartiva® SCI
      for CMC.

      A total of 74 subjects will be enrolled into the pivotal study.

      Follow up visits will occur at the following time points after the surgical procedure: 2
      week, 6 week, 3 month, 6 month, 1 year, 2 year, 3 year, 4 year and 5 year.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 22, 2017</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain measured by the Visual Analog Scale (VAS) scale</measure>
    <time_frame>1 year</time_frame>
    <description>Visual Analog Scale (VAS) Pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Function measured by QuickDASH</measure>
    <time_frame>1 year</time_frame>
    <description>QuickDASH functional score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiographic Findings</measure>
    <time_frame>1 year</time_frame>
    <description>Freedom from radiographic failures post-surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>1 year</time_frame>
    <description>Freedom from Subsequent Secondary Surgical Interventions</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">74</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Cartiva</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Synthetic Cartilage Implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cartiva</intervention_name>
    <description>Synthetic Cartilage Implant</description>
    <arm_group_label>Cartiva</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥ 22 years of age

          -  Refractory to conservative non-operative standard of care treatment for first CMC OA
             lasting for at least 6 months that requires surgical intervention

          -  Eaton classification stage II or III OA of the first CMC joint based on X-rays taken
             within 6 months of the Operative date and evidence of first CMC joint OA based on
             subjective review of associated clinical symptoms

          -  Be willing and able to return for all study-related follow up procedures

        Exclusion Criteria:

          -  Previous CMC implant, trapeziectomy, or LRTI to the affected joint to be treated

          -  History of or current diagnosis of rheumatoid arthritis

          -  OA of the scaphotrapeziotrapezoidal (STT) joint based on radiographic assessment in
             the hand to be treated

          -  Any disease, including uncontrolled diabetes mellitus, which is clinically known to
             impact wound healing ability

          -  Known or suspected allergic reaction to polyvinyl alcohol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Scott Wolfe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Special Surgery, New York</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georgia Hand, Shoulder &amp; Elbow</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana Hand to Shoulder Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital for Specialty Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Rochester</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Derby Hospital</name>
      <address>
        <city>Derby</city>
        <state>Derbyshire</state>
        <zip>DE22 3NE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dorset County Hospital</name>
      <address>
        <city>Dorchester</city>
        <state>Dorset</state>
        <zip>DT2 8DH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Alexandra Hospital</name>
      <address>
        <city>Portsmouth</city>
        <state>Hampshire</state>
        <zip>PO6 3LY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Tees Hospitals</name>
      <address>
        <city>Middlesborough</city>
        <state>North Yorkshire</state>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>August 4, 2017</study_first_submitted>
  <study_first_submitted_qc>August 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 11, 2017</study_first_posted>
  <last_update_submitted>March 20, 2019</last_update_submitted>
  <last_update_submitted_qc>March 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>CMC Joint</keyword>
  <keyword>Osteoarthritis</keyword>
  <keyword>Cartilage Replacement</keyword>
  <keyword>First CMC Joint Osteoarthritis</keyword>
  <keyword>Damaged Articular Surface</keyword>
  <keyword>LRTI</keyword>
  <keyword>Ligament Reconstruction Tendon Interposition</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

